Phase IV Study to Evaluate the Ease of Use, Local Tolerance Safety and Effectiveness of Gonal-f (Filled-by-Mass in a Prefilled Pen).
Latest Information Update: 08 Nov 2021
Price :
$35 *
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 04 Dec 2012 Actual end date changed from 1 Apr 2010 to 1 Jul 2008 as reported by ClinicalTrials.gov record.
- 08 May 2010 New trial record